[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Hormonal Drugs Market Research Report 2024(Status and Outlook)

August 2024 | 144 pages | ID: G98A0E9FA5C7EN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Overview:

Hormone drugs are drugs that use human or animal hormones (including organic substances with the same structure and action principle as hormones) as active ingredients.

The Global Hormonal Drugs Market Size was estimated at USD 113.00 million in 2023 and is projected to reach USD 220.66 million by 2029, exhibiting a CAGR of 11.80% during the forecast period.

This report provides a deep insight into the global Hormonal Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hormonal Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hormonal Drugs market in any manner.

Global Hormonal Drugs Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Merck

Roche

Novartis

Mitsubishi Tanabe Pharma Korea

Anhui Renhe Pharmaceutical

Shanghai ZhongHua Pharmaceutical Nantong

He'nan Xuchang Huaren Pharmaceutical

Wuhan Wujing Pharmaceutical

Harbin Pharmaceutical Group

Changzhou Siyao Pharmaceuticals

Hunan Wzt Pharmaceutical

Tianjin Tianyao Pharmaceutical

Henan Lihua Pharmaceutical

Hubei Tiansheng Pharmaceutica

Shandong Xinhua Pharmaceutical

Huazhong Pharmaceutical

China Resources Zizhu Pharmaceutical

Shanghai CP GENERAL Pharmaceutical

Jiangsu Lianhuan Pharmaceutical

Market Segmentation (by Type)

Intravenous Injection

Take Orally

Topical

Others

Market Segmentation (by Application)

Hospital

Pharmacy

Clinic

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Hormonal Drugs Market
  • Overview of the regional outlook of the Hormonal Drugs Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hormonal Drugs Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Hormonal Drugs
1.2 Key Market Segments
  1.2.1 Hormonal Drugs Segment by Type
  1.2.2 Hormonal Drugs Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 HORMONAL DRUGS MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Hormonal Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
  2.1.2 Global Hormonal Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 HORMONAL DRUGS MARKET COMPETITIVE LANDSCAPE

3.1 Global Hormonal Drugs Sales by Manufacturers (2019-2024)
3.2 Global Hormonal Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Hormonal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Hormonal Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Hormonal Drugs Sales Sites, Area Served, Product Type
3.6 Hormonal Drugs Market Competitive Situation and Trends
  3.6.1 Hormonal Drugs Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Hormonal Drugs Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 HORMONAL DRUGS INDUSTRY CHAIN ANALYSIS

4.1 Hormonal Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF HORMONAL DRUGS MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 HORMONAL DRUGS MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hormonal Drugs Sales Market Share by Type (2019-2024)
6.3 Global Hormonal Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Hormonal Drugs Price by Type (2019-2024)

7 HORMONAL DRUGS MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hormonal Drugs Market Sales by Application (2019-2024)
7.3 Global Hormonal Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Hormonal Drugs Sales Growth Rate by Application (2019-2024)

8 HORMONAL DRUGS MARKET SEGMENTATION BY REGION

8.1 Global Hormonal Drugs Sales by Region
  8.1.1 Global Hormonal Drugs Sales by Region
  8.1.2 Global Hormonal Drugs Sales Market Share by Region
8.2 North America
  8.2.1 North America Hormonal Drugs Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Hormonal Drugs Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Hormonal Drugs Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Hormonal Drugs Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Hormonal Drugs Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 Merck
  9.1.1 Merck Hormonal Drugs Basic Information
  9.1.2 Merck Hormonal Drugs Product Overview
  9.1.3 Merck Hormonal Drugs Product Market Performance
  9.1.4 Merck Business Overview
  9.1.5 Merck Hormonal Drugs SWOT Analysis
  9.1.6 Merck Recent Developments
9.2 Roche
  9.2.1 Roche Hormonal Drugs Basic Information
  9.2.2 Roche Hormonal Drugs Product Overview
  9.2.3 Roche Hormonal Drugs Product Market Performance
  9.2.4 Roche Business Overview
  9.2.5 Roche Hormonal Drugs SWOT Analysis
  9.2.6 Roche Recent Developments
9.3 Novartis
  9.3.1 Novartis Hormonal Drugs Basic Information
  9.3.2 Novartis Hormonal Drugs Product Overview
  9.3.3 Novartis Hormonal Drugs Product Market Performance
  9.3.4 Novartis Hormonal Drugs SWOT Analysis
  9.3.5 Novartis Business Overview
  9.3.6 Novartis Recent Developments
9.4 Mitsubishi Tanabe Pharma Korea
  9.4.1 Mitsubishi Tanabe Pharma Korea Hormonal Drugs Basic Information
  9.4.2 Mitsubishi Tanabe Pharma Korea Hormonal Drugs Product Overview
  9.4.3 Mitsubishi Tanabe Pharma Korea Hormonal Drugs Product Market Performance
  9.4.4 Mitsubishi Tanabe Pharma Korea Business Overview
  9.4.5 Mitsubishi Tanabe Pharma Korea Recent Developments
9.5 Anhui Renhe Pharmaceutical
  9.5.1 Anhui Renhe Pharmaceutical Hormonal Drugs Basic Information
  9.5.2 Anhui Renhe Pharmaceutical Hormonal Drugs Product Overview
  9.5.3 Anhui Renhe Pharmaceutical Hormonal Drugs Product Market Performance
  9.5.4 Anhui Renhe Pharmaceutical Business Overview
  9.5.5 Anhui Renhe Pharmaceutical Recent Developments
9.6 Shanghai ZhongHua Pharmaceutical Nantong
  9.6.1 Shanghai ZhongHua Pharmaceutical Nantong Hormonal Drugs Basic Information
  9.6.2 Shanghai ZhongHua Pharmaceutical Nantong Hormonal Drugs Product Overview
  9.6.3 Shanghai ZhongHua Pharmaceutical Nantong Hormonal Drugs Product Market Performance
  9.6.4 Shanghai ZhongHua Pharmaceutical Nantong Business Overview
  9.6.5 Shanghai ZhongHua Pharmaceutical Nantong Recent Developments
9.7 He'nan Xuchang Huaren Pharmaceutical
  9.7.1 He'nan Xuchang Huaren Pharmaceutical Hormonal Drugs Basic Information
  9.7.2 He'nan Xuchang Huaren Pharmaceutical Hormonal Drugs Product Overview
  9.7.3 He'nan Xuchang Huaren Pharmaceutical Hormonal Drugs Product Market Performance
  9.7.4 He'nan Xuchang Huaren Pharmaceutical Business Overview
  9.7.5 He'nan Xuchang Huaren Pharmaceutical Recent Developments
9.8 Wuhan Wujing Pharmaceutical
  9.8.1 Wuhan Wujing Pharmaceutical Hormonal Drugs Basic Information
  9.8.2 Wuhan Wujing Pharmaceutical Hormonal Drugs Product Overview
  9.8.3 Wuhan Wujing Pharmaceutical Hormonal Drugs Product Market Performance
  9.8.4 Wuhan Wujing Pharmaceutical Business Overview
  9.8.5 Wuhan Wujing Pharmaceutical Recent Developments
9.9 Harbin Pharmaceutical Group
  9.9.1 Harbin Pharmaceutical Group Hormonal Drugs Basic Information
  9.9.2 Harbin Pharmaceutical Group Hormonal Drugs Product Overview
  9.9.3 Harbin Pharmaceutical Group Hormonal Drugs Product Market Performance
  9.9.4 Harbin Pharmaceutical Group Business Overview
  9.9.5 Harbin Pharmaceutical Group Recent Developments
9.10 Changzhou Siyao Pharmaceuticals
  9.10.1 Changzhou Siyao Pharmaceuticals Hormonal Drugs Basic Information
  9.10.2 Changzhou Siyao Pharmaceuticals Hormonal Drugs Product Overview
  9.10.3 Changzhou Siyao Pharmaceuticals Hormonal Drugs Product Market Performance
  9.10.4 Changzhou Siyao Pharmaceuticals Business Overview
  9.10.5 Changzhou Siyao Pharmaceuticals Recent Developments
9.11 Hunan Wzt Pharmaceutical
  9.11.1 Hunan Wzt Pharmaceutical Hormonal Drugs Basic Information
  9.11.2 Hunan Wzt Pharmaceutical Hormonal Drugs Product Overview
  9.11.3 Hunan Wzt Pharmaceutical Hormonal Drugs Product Market Performance
  9.11.4 Hunan Wzt Pharmaceutical Business Overview
  9.11.5 Hunan Wzt Pharmaceutical Recent Developments
9.12 Tianjin Tianyao Pharmaceutical
  9.12.1 Tianjin Tianyao Pharmaceutical Hormonal Drugs Basic Information
  9.12.2 Tianjin Tianyao Pharmaceutical Hormonal Drugs Product Overview
  9.12.3 Tianjin Tianyao Pharmaceutical Hormonal Drugs Product Market Performance
  9.12.4 Tianjin Tianyao Pharmaceutical Business Overview
  9.12.5 Tianjin Tianyao Pharmaceutical Recent Developments
9.13 Henan Lihua Pharmaceutical
  9.13.1 Henan Lihua Pharmaceutical Hormonal Drugs Basic Information
  9.13.2 Henan Lihua Pharmaceutical Hormonal Drugs Product Overview
  9.13.3 Henan Lihua Pharmaceutical Hormonal Drugs Product Market Performance
  9.13.4 Henan Lihua Pharmaceutical Business Overview
  9.13.5 Henan Lihua Pharmaceutical Recent Developments
9.14 Hubei Tiansheng Pharmaceutica
  9.14.1 Hubei Tiansheng Pharmaceutica Hormonal Drugs Basic Information
  9.14.2 Hubei Tiansheng Pharmaceutica Hormonal Drugs Product Overview
  9.14.3 Hubei Tiansheng Pharmaceutica Hormonal Drugs Product Market Performance
  9.14.4 Hubei Tiansheng Pharmaceutica Business Overview
  9.14.5 Hubei Tiansheng Pharmaceutica Recent Developments
9.15 Shandong Xinhua Pharmaceutical
  9.15.1 Shandong Xinhua Pharmaceutical Hormonal Drugs Basic Information
  9.15.2 Shandong Xinhua Pharmaceutical Hormonal Drugs Product Overview
  9.15.3 Shandong Xinhua Pharmaceutical Hormonal Drugs Product Market Performance
  9.15.4 Shandong Xinhua Pharmaceutical Business Overview
  9.15.5 Shandong Xinhua Pharmaceutical Recent Developments
9.16 Huazhong Pharmaceutical
  9.16.1 Huazhong Pharmaceutical Hormonal Drugs Basic Information
  9.16.2 Huazhong Pharmaceutical Hormonal Drugs Product Overview
  9.16.3 Huazhong Pharmaceutical Hormonal Drugs Product Market Performance
  9.16.4 Huazhong Pharmaceutical Business Overview
  9.16.5 Huazhong Pharmaceutical Recent Developments
9.17 China Resources Zizhu Pharmaceutical
  9.17.1 China Resources Zizhu Pharmaceutical Hormonal Drugs Basic Information
  9.17.2 China Resources Zizhu Pharmaceutical Hormonal Drugs Product Overview
  9.17.3 China Resources Zizhu Pharmaceutical Hormonal Drugs Product Market Performance
  9.17.4 China Resources Zizhu Pharmaceutical Business Overview
  9.17.5 China Resources Zizhu Pharmaceutical Recent Developments
9.18 Shanghai CP GENERAL Pharmaceutical
  9.18.1 Shanghai CP GENERAL Pharmaceutical Hormonal Drugs Basic Information
  9.18.2 Shanghai CP GENERAL Pharmaceutical Hormonal Drugs Product Overview
  9.18.3 Shanghai CP GENERAL Pharmaceutical Hormonal Drugs Product Market Performance
  9.18.4 Shanghai CP GENERAL Pharmaceutical Business Overview
  9.18.5 Shanghai CP GENERAL Pharmaceutical Recent Developments
9.19 Jiangsu Lianhuan Pharmaceutical
  9.19.1 Jiangsu Lianhuan Pharmaceutical Hormonal Drugs Basic Information
  9.19.2 Jiangsu Lianhuan Pharmaceutical Hormonal Drugs Product Overview
  9.19.3 Jiangsu Lianhuan Pharmaceutical Hormonal Drugs Product Market Performance
  9.19.4 Jiangsu Lianhuan Pharmaceutical Business Overview
  9.19.5 Jiangsu Lianhuan Pharmaceutical Recent Developments

10 HORMONAL DRUGS MARKET FORECAST BY REGION

10.1 Global Hormonal Drugs Market Size Forecast
10.2 Global Hormonal Drugs Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Hormonal Drugs Market Size Forecast by Country
  10.2.3 Asia Pacific Hormonal Drugs Market Size Forecast by Region
  10.2.4 South America Hormonal Drugs Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Hormonal Drugs by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)

11.1 Global Hormonal Drugs Market Forecast by Type (2025-2030)
  11.1.1 Global Forecasted Sales of Hormonal Drugs by Type (2025-2030)
  11.1.2 Global Hormonal Drugs Market Size Forecast by Type (2025-2030)
  11.1.3 Global Forecasted Price of Hormonal Drugs by Type (2025-2030)
11.2 Global Hormonal Drugs Market Forecast by Application (2025-2030)
  11.2.1 Global Hormonal Drugs Sales (Kilotons) Forecast by Application
  11.2.2 Global Hormonal Drugs Market Size (M USD) Forecast by Application (2025-2030)

12 CONCLUSION AND KEY FINDINGS

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Hormonal Drugs Market Size Comparison by Region (M USD)
Table 5. Global Hormonal Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Hormonal Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Hormonal Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Hormonal Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hormonal Drugs as of 2022)
Table 10. Global Market Hormonal Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Hormonal Drugs Sales Sites and Area Served
Table 12. Manufacturers Hormonal Drugs Product Type
Table 13. Global Hormonal Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Hormonal Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hormonal Drugs Market Challenges
Table 22. Global Hormonal Drugs Sales by Type (Kilotons)
Table 23. Global Hormonal Drugs Market Size by Type (M USD)
Table 24. Global Hormonal Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Hormonal Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Hormonal Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Hormonal Drugs Market Size Share by Type (2019-2024)
Table 28. Global Hormonal Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Hormonal Drugs Sales (Kilotons) by Application
Table 30. Global Hormonal Drugs Market Size by Application
Table 31. Global Hormonal Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Hormonal Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Hormonal Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Hormonal Drugs Market Share by Application (2019-2024)
Table 35. Global Hormonal Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Hormonal Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Hormonal Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Hormonal Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Hormonal Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Hormonal Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Hormonal Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Hormonal Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Merck Hormonal Drugs Basic Information
Table 44. Merck Hormonal Drugs Product Overview
Table 45. Merck Hormonal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Merck Business Overview
Table 47. Merck Hormonal Drugs SWOT Analysis
Table 48. Merck Recent Developments
Table 49. Roche Hormonal Drugs Basic Information
Table 50. Roche Hormonal Drugs Product Overview
Table 51. Roche Hormonal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Roche Business Overview
Table 53. Roche Hormonal Drugs SWOT Analysis
Table 54. Roche Recent Developments
Table 55. Novartis Hormonal Drugs Basic Information
Table 56. Novartis Hormonal Drugs Product Overview
Table 57. Novartis Hormonal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Novartis Hormonal Drugs SWOT Analysis
Table 59. Novartis Business Overview
Table 60. Novartis Recent Developments
Table 61. Mitsubishi Tanabe Pharma Korea Hormonal Drugs Basic Information
Table 62. Mitsubishi Tanabe Pharma Korea Hormonal Drugs Product Overview
Table 63. Mitsubishi Tanabe Pharma Korea Hormonal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Mitsubishi Tanabe Pharma Korea Business Overview
Table 65. Mitsubishi Tanabe Pharma Korea Recent Developments
Table 66. Anhui Renhe Pharmaceutical Hormonal Drugs Basic Information
Table 67. Anhui Renhe Pharmaceutical Hormonal Drugs Product Overview
Table 68. Anhui Renhe Pharmaceutical Hormonal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Anhui Renhe Pharmaceutical Business Overview
Table 70. Anhui Renhe Pharmaceutical Recent Developments
Table 71. Shanghai ZhongHua Pharmaceutical Nantong Hormonal Drugs Basic Information
Table 72. Shanghai ZhongHua Pharmaceutical Nantong Hormonal Drugs Product Overview
Table 73. Shanghai ZhongHua Pharmaceutical Nantong Hormonal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Shanghai ZhongHua Pharmaceutical Nantong Business Overview
Table 75. Shanghai ZhongHua Pharmaceutical Nantong Recent Developments
Table 76. He'nan Xuchang Huaren Pharmaceutical Hormonal Drugs Basic Information
Table 77. He'nan Xuchang Huaren Pharmaceutical Hormonal Drugs Product Overview
Table 78. He'nan Xuchang Huaren Pharmaceutical Hormonal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. He'nan Xuchang Huaren Pharmaceutical Business Overview
Table 80. He'nan Xuchang Huaren Pharmaceutical Recent Developments
Table 81. Wuhan Wujing Pharmaceutical Hormonal Drugs Basic Information
Table 82. Wuhan Wujing Pharmaceutical Hormonal Drugs Product Overview
Table 83. Wuhan Wujing Pharmaceutical Hormonal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Wuhan Wujing Pharmaceutical Business Overview
Table 85. Wuhan Wujing Pharmaceutical Recent Developments
Table 86. Harbin Pharmaceutical Group Hormonal Drugs Basic Information
Table 87. Harbin Pharmaceutical Group Hormonal Drugs Product Overview
Table 88. Harbin Pharmaceutical Group Hormonal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Harbin Pharmaceutical Group Business Overview
Table 90. Harbin Pharmaceutical Group Recent Developments
Table 91. Changzhou Siyao Pharmaceuticals Hormonal Drugs Basic Information
Table 92. Changzhou Siyao Pharmaceuticals Hormonal Drugs Product Overview
Table 93. Changzhou Siyao Pharmaceuticals Hormonal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Changzhou Siyao Pharmaceuticals Business Overview
Table 95. Changzhou Siyao Pharmaceuticals Recent Developments
Table 96. Hunan Wzt Pharmaceutical Hormonal Drugs Basic Information
Table 97. Hunan Wzt Pharmaceutical Hormonal Drugs Product Overview
Table 98. Hunan Wzt Pharmaceutical Hormonal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Hunan Wzt Pharmaceutical Business Overview
Table 100. Hunan Wzt Pharmaceutical Recent Developments
Table 101. Tianjin Tianyao Pharmaceutical Hormonal Drugs Basic Information
Table 102. Tianjin Tianyao Pharmaceutical Hormonal Drugs Product Overview
Table 103. Tianjin Tianyao Pharmaceutical Hormonal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Tianjin Tianyao Pharmaceutical Business Overview
Table 105. Tianjin Tianyao Pharmaceutical Recent Developments
Table 106. Henan Lihua Pharmaceutical Hormonal Drugs Basic Information
Table 107. Henan Lihua Pharmaceutical Hormonal Drugs Product Overview
Table 108. Henan Lihua Pharmaceutical Hormonal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Henan Lihua Pharmaceutical Business Overview
Table 110. Henan Lihua Pharmaceutical Recent Developments
Table 111. Hubei Tiansheng Pharmaceutica Hormonal Drugs Basic Information
Table 112. Hubei Tiansheng Pharmaceutica Hormonal Drugs Product Overview
Table 113. Hubei Tiansheng Pharmaceutica Hormonal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Hubei Tiansheng Pharmaceutica Business Overview
Table 115. Hubei Tiansheng Pharmaceutica Recent Developments
Table 116. Shandong Xinhua Pharmaceutical Hormonal Drugs Basic Information
Table 117. Shandong Xinhua Pharmaceutical Hormonal Drugs Product Overview
Table 118. Shandong Xinhua Pharmaceutical Hormonal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Shandong Xinhua Pharmaceutical Business Overview
Table 120. Shandong Xinhua Pharmaceutical Recent Developments
Table 121. Huazhong Pharmaceutical Hormonal Drugs Basic Information
Table 122. Huazhong Pharmaceutical Hormonal Drugs Product Overview
Table 123. Huazhong Pharmaceutical Hormonal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Huazhong Pharmaceutical Business Overview
Table 125. Huazhong Pharmaceutical Recent Developments
Table 126. China Resources Zizhu Pharmaceutical Hormonal Drugs Basic Information
Table 127. China Resources Zizhu Pharmaceutical Hormonal Drugs Product Overview
Table 128. China Resources Zizhu Pharmaceutical Hormonal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. China Resources Zizhu Pharmaceutical Business Overview
Table 130. China Resources Zizhu Pharmaceutical Recent Developments
Table 131. Shanghai CP GENERAL Pharmaceutical Hormonal Drugs Basic Information
Table 132. Shanghai CP GENERAL Pharmaceutical Hormonal Drugs Product Overview
Table 133. Shanghai CP GENERAL Pharmaceutical Hormonal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Shanghai CP GENERAL Pharmaceutical Business Overview
Table 135. Shanghai CP GENERAL Pharmaceutical Recent Developments
Table 136. Jiangsu Lianhuan Pharmaceutical Hormonal Drugs Basic Information
Table 137. Jiangsu Lianhuan Pharmaceutical Hormonal Drugs Product Overview
Table 138. Jiangsu Lianhuan Pharmaceutical Hormonal Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Jiangsu Lianhuan Pharmaceutical Business Overview
Table 140. Jiangsu Lianhuan Pharmaceutical Recent Developments
Table 141. Global Hormonal Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 142. Global Hormonal Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 143. North America Hormonal Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 144. North America Hormonal Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 145. Europe Hormonal Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 146. Europe Hormonal Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 147. Asia Pacific Hormonal Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 148. Asia Pacific Hormonal Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 149. South America Hormonal Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 150. South America Hormonal Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 151. Middle East and Africa Hormonal Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 152. Middle East and Africa Hormonal Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 153. Global Hormonal Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 154. Global Hormonal Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 155. Global Hormonal Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 156. Global Hormonal Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 157. Global Hormonal Drugs Market Size Forecast by Application (2025-2030) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Hormonal Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hormonal Drugs Market Size (M USD), 2019-2030
Figure 5. Global Hormonal Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Hormonal Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hormonal Drugs Market Size by Country (M USD)
Figure 11. Hormonal Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Hormonal Drugs Revenue Share by Manufacturers in 2023
Figure 13. Hormonal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Hormonal Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Hormonal Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Hormonal Drugs Market Share by Type
Figure 18. Sales Market Share of Hormonal Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Hormonal Drugs by Type in 2023
Figure 20. Market Size Share of Hormonal Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Hormonal Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Hormonal Drugs Market Share by Application
Figure 24. Global Hormonal Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Hormonal Drugs Sales Market Share by Application in 2023
Figure 26. Global Hormonal Drugs Market Share by Application (2019-2024)
Figure 27. Global Hormonal Drugs Market Share by Application in 2023
Figure 28. Global Hormonal Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Hormonal Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Hormonal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Hormonal Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Hormonal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Hormonal Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Hormonal Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Hormonal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Hormonal Drugs Sales Market Share by Country in 2023
Figure 37. Germany Hormonal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Hormonal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Hormonal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Hormonal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Hormonal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Hormonal Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Hormonal Drugs Sales Market Share by Region in 2023
Figure 44. China Hormonal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Hormonal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Hormonal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Hormonal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Hormonal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Hormonal Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Hormonal Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Hormonal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Hormonal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Hormonal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Hormonal Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Hormonal Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Hormonal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Hormonal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Hormonal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Hormonal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Hormonal Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Hormonal Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Hormonal Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Hormonal Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Hormonal Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Hormonal Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Hormonal Drugs Market Share Forecast by Application (2025-2030)


More Publications